| Q37013041 | A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals |
| Q28483747 | A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies |
| Q37671082 | A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model |
| Q35490817 | A treatment reengagement intervention for syringe exchangers |
| Q39604114 | Access to resources for substance users in Harlem, New York City: service provider and client perspectives |
| Q36274505 | Adherence to hepatitis B virus vaccination at syringe exchange sites |
| Q34687295 | Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts |
| Q41927216 | Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV/AIDS: perspectives of HIV surveillance experts and service providers |
| Q34669393 | Benefits of concurrent syringe exchange and substance abuse treatment participation |
| Q78350663 | Bridge to services: drug injectors' awareness and utilization of drug user treatment and social service referrals, medical care, and HIV testing provided by needle exchange programs |
| Q73265934 | Can We Protect Drug Users from Hepatitis C? |
| Q36272795 | Challenges in motivating treatment enrollment in community syringe exchange participants |
| Q44430298 | Changes in Health Insurance and Payment for Substance Use Treatment |
| Q36272696 | Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998 |
| Q92139384 | Confronting the opioid epidemic: public opinion toward the expansion of treatment services in Virginia |
| Q45190469 | Critical condition facing needle exchange programs: the politics of science |
| Q42687568 | Demystifying the injection drug user: willingness to participate in traditional drug treatment services among participants in a needle exchange program |
| Q33667902 | Development and evaluation of a community-based buprenorphine treatment intervention |
| Q28249288 | Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence |
| Q42692058 | Drug user treatment referrals and entry among participants of a needle exchange program |
| Q34250168 | Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups |
| Q36274801 | Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. |
| Q37272781 | Expanding the public health benefits of syringe exchange programs |
| Q36376967 | Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial |
| Q43570044 | Factors associated with readiness to change drug use among needle-exchange users |
| Q44368425 | Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance |
| Q53505317 | Giving means receiving: the protective effect of social capital on binge drinking on college campuses. |
| Q33774978 | HIV/hepatitis prevention in drug abuse treatment programs: guidance from research |
| Q37862458 | Health services usage by Alaskan injection drug users |
| Q37368505 | Hospital- versus community-based syringe exchange: a randomized controlled trial |
| Q35925986 | Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes |
| Q36085378 | Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons |
| Q40267607 | Malmö Treatment Referral and Intervention Study (MATRIS)—effective referral from syringe exchange to treatment for heroin dependence: a pilot randomized controlled trial. |
| Q52289434 | Medicaid coverage and access to publicly funded opiate treatment. |
| Q57259768 | Needle exchange and difficulty with needle access during an ongoing HIV epidemic |
| Q27024650 | Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research |
| Q42685835 | Needle exchange as a safe haven in an unsafe world. |
| Q51773850 | Needle exchange program utilization and entry into drug user treatment: is there a long-term connection in Baltimore, Maryland? |
| Q34506338 | Needle-exchange attendance and health care utilization promote entry into detoxification |
| Q34511319 | Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors |
| Q39760693 | Secondary syringe exchange among users of 23 California syringe exchange programs |
| Q42689910 | Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation |
| Q36714627 | Service use and barriers to care among heroin users: results from a national survey. |
| Q61712970 | Structural interventions to improve opiate maintenance |
| Q51688513 | Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. |
| Q34743029 | The impact of needle exchange-based health services on emergency department use. |
| Q52889079 | Trends in crime and the introduction of a needle exchange program. |
| Q37661224 | Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs |
| Q37347124 | Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, Maryland. |